{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:49:44Z","timestamp":1782452984165,"version":"3.54.5"},"reference-count":31,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1157741"],"award-info":[{"award-number":["APP1157741"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Tumor tissue biopsy is often limited for non-small cell lung cancer (NSCLC) patients and alternative sources of tumoral information are desirable to determine molecular alterations such as anaplastic lymphoma kinase (ALK) rearrangements. Circulating tumor cells (CTCs) are an appealing component of liquid biopsies, which can be sampled serially over the course of treatment. In this study, we enrolled a cohort of ALK-positive (n = 8) and ALK-negative (n = 12) NSCLC patients, enriched for CTCs using spiral microfluidic technology and performed DNA fluorescent in situ hybridization (FISH) for ALK. CTCs were identified in 12\/20 NSCLC patients ranging from 1 to 26 CTCs\/7.5 mL blood. Our study revealed that 3D imaging of CTCs for ALK translocations captured a well-defined separation of 3\u2032 and 5\u2032 signals indicative of ALK translocations and overlapping 3\u2032\/5\u2032 signal was easily resolved by imaging through the nuclear volume. This study provides proof-of-principle for the use of 3D DNA FISH in the determination of CTC ALK translocations in NSCLC.<\/jats:p>","DOI":"10.3390\/cells9061465","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T12:16:57Z","timestamp":1592223417000},"page":"1465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-7350","authenticated-orcid":false,"given":"Arutha","family":"Kulasinghe","sequence":"first","affiliation":[{"name":"The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4035, Australia"},{"name":"Saliva and Liquid Biopsy Translational Research Team, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove, QLD 4035, Australia"},{"name":"Translational Research Institute, Woolloongabba, QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenkai","family":"Lim","sequence":"additional","affiliation":[{"name":"The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4035, Australia"},{"name":"Saliva and Liquid Biopsy Translational Research Team, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove, QLD 4035, Australia"},{"name":"Translational Research Institute, Woolloongabba, QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kapeleris","sequence":"additional","affiliation":[{"name":"The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4035, Australia"},{"name":"Saliva and Liquid Biopsy Translational Research Team, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove, QLD 4035, Australia"},{"name":"Translational Research Institute, Woolloongabba, QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Warkiani","sequence":"additional","affiliation":[{"name":"The School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW 2007, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"O\u2019Byrne","sequence":"additional","affiliation":[{"name":"The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4035, Australia"},{"name":"Translational Research Institute, Woolloongabba, QLD 4102 Australia"},{"name":"Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-8259","authenticated-orcid":false,"given":"Chamindie","family":"Punyadeera","sequence":"additional","affiliation":[{"name":"The School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD 4035, Australia"},{"name":"Saliva and Liquid Biopsy Translational Research Team, Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove, QLD 4035, Australia"},{"name":"Translational Research Institute, Woolloongabba, QLD 4102 Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"ref_1","unstructured":"Noone, A.M., Howlander, N., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., and Lewis, D.R. (2020, January 10). SEER Cancer Statistics Review, Available online: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2015\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-10-0851","article-title":"Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment","volume":"16","author":"Camidge","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2013.01.004","article-title":"ALK status testing in non-small cell lung carcinoma: Correlation between ultrasensitive IHC and FISH","volume":"15","author":"Minca","year":"2013","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/1078-0432.CCR-10-1591","article-title":"Targeting anaplastic lymphoma kinase in lung cancer","volume":"17","author":"Shaw","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa1007478","article-title":"EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors","volume":"363","author":"Choi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.21037\/atm.2019.03.28","article-title":"Liquid biopsy for lung cancers: An update on recent developments","volume":"7","author":"Revelo","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41591-019-0593-1","article-title":"Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse","volume":"25","author":"Chemi","year":"2019","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cell.2017.01.026","article-title":"SnapShot: Circulating Tumor Cells","volume":"168","author":"Dive","year":"2017","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fonc.2018.00311","article-title":"The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer","volume":"8","author":"Kapeleris","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41378-019-0045-6","article-title":"Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel","volume":"5","author":"Zhou","year":"2019","journal-title":"Microsyst. Nanoeng."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1200\/JCO.2012.44.5932","article-title":"Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer","volume":"31","author":"Pailler","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.21037\/tlcr.2017.07.01","article-title":"Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer\u2014ready for prime-time?","volume":"6","author":"Pailler","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1002\/cam4.1832","article-title":"The prognostic significance of circulating tumor cells in head and neck and non-small-cell lung cancer","volume":"7","author":"Kulasinghe","year":"2018","journal-title":"Cancer Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kulasinghe, A., Kapeleris, J., Cooper, C., Warkiani, M.E., O\u2019Byrne, K., and Punyadeera, C. (2019). Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. Cancers, 11.","DOI":"10.3390\/cancers11030380"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23251","DOI":"10.18632\/oncotarget.8136","article-title":"Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer","volume":"7","author":"Tan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"59408","DOI":"10.18632\/oncotarget.19722","article-title":"Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients","volume":"8","author":"Provencio","year":"2017","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lin, P.P. (2018). Aneuploid CTC and CEC. Diagnostics, 8.","DOI":"10.3390\/diagnostics8020026"},{"key":"ref_19","first-page":"18","article-title":"Smart 3D-fish: Automation of distance analysis in nuclei of interphase cells by image processing","volume":"67","author":"Messaoudi","year":"2005","journal-title":"Cytom. Part A J. Int. Soc. Anal. Cytol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bolland, D.J., King, M.R., Reik, W., Corcoran, A.E., and Krueger, C. (2013). Robust 3D DNA FISH using directly labeled probes. J. Vis. Exp., e50587.","DOI":"10.3791\/50587"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Khoo, B.L., Warkiani, M.E., Tan, D.S., Bhagat, A.A., Irwin, D., Lau, D.P., Lim, A.S., Lim, K.H., Krisna, S.S., and Lim, W.T. (2014). Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0099409"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/annonc\/mds137","article-title":"ALK-gene rearrangement: A comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma","volume":"23","author":"Ilie","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fonc.2019.01139","article-title":"Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I-III Non-small Cell Lung Cancer Patients","volume":"9","author":"Dong","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1158\/1078-0432.CCR-19-1176","article-title":"Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer","volume":"25","author":"Pailler","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1078-0432.CCR-11-3148","article-title":"Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib","volume":"18","author":"Punnoose","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1111\/bju.13631","article-title":"Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer","volume":"120","author":"McDaniel","year":"2017","journal-title":"BJU Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Magbanua, M.J.M., and Park, J.W. (2017). Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer. Isolation and Molecular Characterization of Circulating Tumor Cells, Springer International Publishing.","DOI":"10.1007\/978-3-319-55947-6"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"67355","DOI":"10.18632\/oncotarget.18641","article-title":"Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device","volume":"8","author":"Marsavela","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41598-017-19117-9","article-title":"A Collective Route to Head and Neck Cancer Metastasis","volume":"8","author":"Kulasinghe","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"42517","DOI":"10.1038\/srep42517","article-title":"Enrichment of circulating head and neck tumour cells using spiral microfluidic technology","volume":"7","author":"Kulasinghe","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nprot.2016.003","article-title":"Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics","volume":"11","author":"Warkiani","year":"2016","journal-title":"Nat. Protoc."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/6\/1465\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:39:08Z","timestamp":1760175548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/6\/1465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["cells9061465"],"URL":"https:\/\/doi.org\/10.3390\/cells9061465","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}